Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michael J. Carr MD"'
Autor:
Daniel M. Balkin MD, PhD, Gregory J. Tranah PhD, Frederick Wang MD, Cristina O’Donoghue MD, MPH, Emily A. Morell MD, Caitlin Porubsky DO, Mehdi Nosrati MS, Edith M. Vaquero BA, HanKyul Kim BA, Michael J. Carr MD, Jaime L. Montilla-Soler MD, Max C. Wu MD, Donald M. Torre CNMT, Mohammed Kashani-Sabet MD, Jonathan S. Zager MD, FACS, Stanley P. Leong MD, MS, FACS
Publikováno v:
Cancer Control, Vol 30 (2023)
Background Technetium-99m-labeled Tilmanocept, a multivalent mannose, is readily internalized by the CD206 surface receptor on macrophages and dendritic cells which are abundantly present in lymph nodes. We want to examine the drainage patterns of Te
Externí odkaz:
https://doaj.org/article/639819a40c604669a669db7d227e2f2d
Autor:
Michael J. Carr MD, MS, James Sun MD, Jonathan B. Cohen MD, Jinhong Liu MD, Andrew A. Serdiuk DO, Stephen R. Stewart CCP, Navin Doobay CAA, Andrew Duclos CRNA, David A. Seal CRNA, Junsung Choi MD, Jonathan S. Zager MD
Publikováno v:
Cancer Control, Vol 27 (2020)
Patients with unresectable hepatic metastases, from uveal or ocular melanoma, are challenging to treat with an overall poor prognosis. Although over the past decade significant advances in systemic therapies have been made, metastatic disease to the
Externí odkaz:
https://doaj.org/article/6e610c94c7a84080b6b7e56f02a6f3b0
Autor:
Erin McClure BS, Michael J Carr MD, MS, Ayushi Patel BS, Syed Mahrukh Hussnain Naqvi MD, MPH, Youngchul Kim PhD, Michael Harrington MD, Wayne Cruse MD, Ricardo J Gonzalez MD, Vernon K Sondak MD, Amod A Sarnaik MD, Jane L Messina MD, Jonathan S Zager MD
Publikováno v:
Cancer Control, Vol 30 (2023)
Background Atypical fibroxanthomas (AFX) are rare malignant cutaneous neoplasms. Unfortunately, limited clinicopathologic and outcomes data on this cancer exists. Objective We report the clinical, pathologic, and treatment characteristics, as well as
Externí odkaz:
https://doaj.org/article/c7abe111593d48f8891c7567835fa5eb